文献速递烧伤创面修复

复方硝酸铈-磺胺嘧啶银乳膏治疗烧伤创面安全有效:烧伤中心4年经验

Compounded Cerium Nitrate-Silver Sulfadiazine Cream is Safe and Effective for the Treatment of Burn Wounds: A Burn Center's 4-Year Experience.
PubMed 文献 · J Burn Care Res · 2022-01-01

该回顾性研究纳入2014年7月至2018年7月间157例使用复方硝酸铈-磺胺嘧啶银(Ce-SSD)乳膏的烧伤患者,评估高铁血红蛋白血症监测方案。中位年龄59岁,TBSA 8.5%,调整Baux评分76,吸入性损伤占9.9%。9.6%患者发生高铁血红蛋白血症,其中73.3%在首次用药72小时后达峰;结论:Ce-SSD作为延迟手术的临时覆盖安全有效,TBSA<20%无症状者无需连续血气监测。

要点

  • Ce-SSD可安全用于烧伤创面临时覆盖,等待切削痂植皮。
  • TBSA≥20%者高铁血红蛋白血症风险显著增高(OR 9.318)。
  • TBSA<20%无症状患者无需连续血气监测。

核心结论

  • Ce-SSD用于烧伤创面临时覆盖安全有效,TBSA<20%无症状者无需连续血气监测。

研究设计与样本

  • 回顾性研究,纳入2014年7月至2018年7月使用Ce-SSD的157例烧伤患者,评估高铁血红蛋白血症监测方案。

主要发现

  • 中位年龄59岁(IQR 47-70.5),TBSA 8.5%(IQR 3-27),调整Baux评分76(IQR 59-94),吸入性损伤占9.9%。
  • 9.6%(n=15)患者发生高铁血红蛋白血症,其中73.3%(n=11)最大高铁血红蛋白水平在首次用药后≥72小时。
  • 仅1例出现临床显著的高铁血红蛋白血症。
  • Ce-SSD剂量及暴露天数均非显著预测因素。

临床怎么用

  • Ce-SSD可用于烧伤创面临时覆盖,等待切削痂植皮。
  • TBSA<20%的无症状患者可安全使用Ce-SSD,无需连续血气监测。
  • TBSA≥20%患者应警惕高铁血红蛋白血症症状,但常规血气监测非必需。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Wound infections and sepsis are significant causes of morbidity after burn injury and can be alleviated by early excision and grafting. In situations that preclude early surgery, topical agents allow for a safer delay. Cerium nitrate compounded with silver sulfadiazine (Ce-SSD) is a burn cream that provides broad antibacterial activity, forms a temporary barrier, and promotes re-epithelialization. Methemoglobinemia is a rare, but oft-cited, systemic complication of Ce-SSD. In this retrospective review, 157 patients treated with Ce-SSD between July 2014 and July 2018 were identified, and the monitoring protocol for methemoglobinemia during Ce-SSD treatment was evaluated. The median age was 59 years (interquartile range [IQR], 47-70.5 years), with TBSA of 8.5% (IQR, 3-27), adjusted Baux score of 76 (IQR, 59-94), and inhalation injury present in 9.9% of patients. Primary endpoints included incidence of symptomatic and asymptomatic methemoglobinemia. Of the 9.6% (n = 15) of patients with methemoglobinemia, 73.3% (n = 11) had maximum methemoglobin levels ≥72 hours from the time of the first application. One patient developed clinically significant methemoglobinemia. Patients with TBSA ≥20% were more likely to develop methemoglobinemia (odds ratio 9.318, 95% confidence interval 2.078-65.73, P = .0078); however, neither Ce-SSD doses nor days of exposure were significant predictors. Ce-SSD application to temporize burn wounds until excision and grafting is safe, effective, and, in asymptomatic patients with TBSA <20%, can be used without serial blood gas monitoring. Vigilant monitoring for symptoms should be performed in patients with TBSA ≥20%, but routine blood gases are not necessary.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Reese AD, Keyloun JW, Garg G, et al. Compounded Cerium Nitrate-Silver Sulfadiazine Cream is Safe and Effective for the Treatment of Burn Wounds: A Burn Center's 4-Year Experience. J Burn Care Res. 2022. PMID: 34543402. doi:10.1093/jbcr/irab180

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。